Related Experiment Videos
[Solacy and non-specific chronic laryngitis].
Revue De Laryngologie - Otologie - Rhinologie
|January 1, 1989
Summary
SOLACY significantly improved chronic laryngitis symptoms in adults, reducing dysphonia and discomfort. This treatment also enhanced laryngeal mucosa appearance and was well-tolerated.
Area of Science:
- Otolaryngology
- Pharmacology
Context:
- Chronic laryngitis affects numerous adults, impacting vocal function and quality of life.
- Non-specific chronic laryngitis presents persistent laryngeal inflammation and discomfort.
Purpose:
- To evaluate the efficacy and tolerability of SOLACY in adult patients with non-specific chronic laryngitis.
Summary:
- Ten adult subjects with chronic laryngitis received SOLACY (4 capsules daily for 4 months).
- Post-treatment assessments showed significant reductions in dysphonia and self-reported discomfort.
- Fibroscopic examination revealed improved laryngeal mucosa, particularly reduced congestion.
Impact:
- SOLACY demonstrates therapeutic potential for managing chronic laryngitis symptoms.
- The study indicates SOLACY's effectiveness in improving laryngeal tissue health and patient-reported outcomes.
- SOLACY was well-tolerated, suggesting a favorable safety profile for chronic laryngitis treatment.